Fentanyl use disorder characterized by unprescribed use of transdermal patches: a case report

References

• Muijsers RB, Wagstaff AJ. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs. 2001;61(15):2289–307. doi:10.2165/00003495-200161150-00014.
   PubMed Web of Science ®Google Scholar
• Jeal W, Benfield P. Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control. Drugs. 1997;53(1):109–38. doi:10.2165/00003495-199753010-00011.
   PubMed Web of Science ®Google Scholar
• Kornick CA, Santiago-Palma J, Moryl N, Payne R, Obbens EA. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain. Drug Saf. 2003;26(13):951–73. doi:10.2165/00002018-200326130-00004.
   PubMed Web of Science ®Google Scholar
• Jumbelic MI. Deaths with transdermal fentanyl patches. Am J Forensic Med Pathol. 2010;31(1):18–21. doi:10.1097/PAF.0b013e31818738b8.
   PubMed Web of Science ®Google Scholar
• Liappas I, Dimopoulos N, Mellos E, Gitsa O, Liappas A, Rabavilas A. Oral transmucosal abuse of transdermal fentanyl. J Psychopharmacol. 2004;18(2):277–80. doi:10.1177/0269881104042634.
   PubMed Web of Science ®Google Scholar
• Adriaensen H, Vissers K, Noorduin H, Meert T. Opioid tolerance and dependence: an inevitable consequence of chronic treatment? Acta Anaesthesiol Belg. 2003;54(1):37–48.
   PubMedGoogle Scholar
• Kuczyńska K, Grzonkowski P, Kacprzak Ł, Zawilska JB. Abuse of fentanyl: an emerging problem to face. Forensic Sci Int. 2018;289:207–14. 1doi:10.1016/j.forsciint.2018.05.042.
   PubMed Web of Science ®Google Scholar
• Woodall KL, Martin TL, McLellan BA. Oral abuse of fentanyl patches (Duragesic): seven case reports. J Forensic Sci. 2008;53(1):222–5. doi:10.1111/j.1556-4029.2007.00597.x.
   PubMed Web of Science ®Google Scholar
• Coon TP, Miller M, Kaylor D, Jones-Spangle K. Rectal insertion of fentanyl patches: a new route of toxicity. Ann Emerg Med. 2005;46(5):473. doi:10.1016/j.annemergmed.2005.06.450.
   PubMed Web of Science ®Google Scholar
• D’Orazio JL, Fischel JA. Recurrent respiratory depression associated with fentanyl transdermal patch gel reservoir ingestion. J Emerg Med. 2012;42(5):543–48. doi:10.1016/j.jemermed.2011.03.011.
   PubMed Web of Science ®Google Scholar
• Mrvos R, Feuchter AC, Katz KD, Duback-Morris LF, Brooks DE, Krenzelok EP. Whole fentanyl patch ingestion: a multi-center case series. J Emerg Med. 2012;42(5):549–52. doi:10.1016/j.jemermed.2011.05.017.
   PubMed Web of Science ®Google Scholar
• Prosser JM, Jones BE, Nelson L. Complications of oral exposure to fentanyl transdermal delivery system patches. J Med Toxicol. 2010;6(4):443–7. doi:10.1007/s13181-010-0092-8.
   PubMedGoogle Scholar
• Carson HJ, Knight LD, Dudley MH, Garg U. A fatality involving an unusual route of fentanyl delivery: chewing and aspirating the transdermal patch. Leg Med (Tokyo). 2010;12(3):157–9. doi:10.1016/j.legalmed.2010.03.001.
   PubMed Web of Science ®Google Scholar
• Kimergård A, Dunne J, Bøgen A, Hindersson P, Breindahl T. Characteristics of opioid-maintained clients smoking fentanyl patches: the importance of confirmatory drug analysis illustrated by a case series and mini-review. Drug Test Anal. 2018;10(6):917–26. doi: 10.1002/dta.2397
   PubMed Web of Science ®Google Scholar
• Jost U, Wolter E, Bohrer H. [Repeated improper intravenous injection of fentanyl from a transdermal system]. Dtsch Med Wochenschr. 2004;129(7):313–4. doi:10.1055/s-2004-818627.
   PubMed Web of Science ®Google Scholar
• Kuhlman JJJr, McCaulley R, Valouch TJ, Behonick GS. Fentanyl use, misuse, and abuse: a summary of 23 postmortem cases. J Anal Toxicol. 2003;27(7):499–504. doi:10.1093/jat/27.7.499.
   PubMed Web of Science ®Google Scholar
• Lilleng PK, Mehlum LI, Bachs L, Morild I. Deaths after intravenous misuse of transdermal fentanyl. J Forensic Sci. 2004;49(6):1364–66.
   PubMed Web of Science ®Google Scholar
• Marquardt KA, Tharratt RS. Inhalation abuse of fentanyl patch. J Toxicol Clin Toxicol. 1994;32(1):75–78. doi:10.3109/15563659409000433.
   PubMed Web of Science ®Google Scholar
• Reeves MD, Ginifer CJ. Fatal intravenous misuse of transdermal fentanyl. Med J Aust. 2002;177(10):552–3. doi:10.5694/j.1326-5377.2003.tb05342.x.
   PubMed Web of Science ®Google Scholar
• Schauer CK, Shand JA, Reynolds TM. The fentanyl patch boil-up - a novel method of opioid abuse. Basic Clin Pharmacol Toxicol. 2015;117(5):358–59. doi:10.1111/bcpt.12412.
   PubMed Web of Science ®Google Scholar
• Tharp AM, Winecker RE, Winston DC. Fatal intravenous fentanyl abuse: four cases involving extraction of fentanyl from transdermal patches. Am J Forensic Med Pathol. 2004;25(2):178–81. doi:10.1097/01.paf.0000127398.67081.11.
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Ellis MS, Kasper ZA. Increases in self-reported fentanyl use among a population entering drug treatment: the need for systematic surveillance of illicitly manufactured opioids. Drug Alcohol Depend. 2017;177:101–3. doi:10.1016/j.drugalcdep.2017.04.004.
   PubMed Web of Science ®Google Scholar
• Krause D, Plörer D, Koller G, Martin G, Winter C, Adam R, Canolli M, Al-Iassin J, Musselmann R, Walcher S, et al. High concomitant misuse of fentanyl in subjects on opioid maintenance treatment. Subst Use Misuse. 2017;52(5):639–45. doi: 10.1080/10826084.2016.124657
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association [APA]. 2017. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. Arlington, VA: APA.
   Google Scholar
• Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, Tugwell P, Kiene H, Helfand M, Altman DG, Sox H, et al. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. 2017;89:218–35. doi: 10.1016/j.jclinepi.2017.04.026
   PubMed Web of Science ®Google Scholar
• Gecici O, Gokmen Z, Nebioglu M. Fentanyl dependence caused by the non-medical use: a case report. Klinik Psikofarmakol Bülteni. 2010;20(3):255–7. doi:10.1080/10177833.2010.11790668.
   Google Scholar
• Calle EA, Planas DJ, Farriols DC. Transdermal fentanyl dependency in the treatment of chronic pain in the elderly: presentation of a case. Rev Esp Geriatr Gerontol. 2011;46(3):179.
   PubMedGoogle Scholar
• Sarisoy G, Korkmaz IZ, Ozturan DD, Pazvantoglu O. Fentanyl dependence associated with the use of transdermal fentanyl in a cancer patient: a case report. Dusunen Adam the Journal of Psychiatry and Neurological Sciences. 2013;26(3):307.
   Google Scholar
• Anderson DT, Muto JJ. Duragesic® transdermal patch: postmortem tissue distribution of fentanyl in 25 cases. J Anal Toxicol. 2000;24(7):627–34. doi:10.1093/jat/24.7.627.
   PubMed Web of Science ®Google Scholar